| Time | Event |
|---|---|
| 7:15 - 7:50 am | Breakfast |
| 7:50 - 8:00 am | Introductions |
|
8:00 - 9:50 am |
Patient Journey Session |
|
8:00 - 9:00 am |
Patient, Caregiver/Family Experience - Impact of Diagnosis and Treatment
|
|
9:00 - 9:40 am |
Management of Immune-Related Adverse Events in Clinical Practice |
| 9:40 - 10:00 am | Coffee Break |
| 10:00 - 10:30 am | Clear Cell vs. Non-Clear Cell RCC Diagnosis and Implications Shams Halat, MD |
| 10:30 - 10:45 am | Q & A |
| 10:45 - 11:15 am | Any Role for Neoadjuvant Systemic Therapy in 2019? Jonathan Silberstein, MD |
| 11:15 - 11:30 am | Q & A |
| 11:30 am - 12:00 pm | RCC in the Era of Precision Medicine Spencer Krane, MD |
| 12:00 - 12:15 pm | Q & A |
| 12:15 - 1:45 pm | Lunch KEYNOTE Speaker - The Role of Patient Advocacy Groups in Oncology Dena Battle - KCCure President |
| 1:45 - 2:15 pm | The Role of Stereotactic Radiation Therapy Audrey Dang, MD |
| 2:15 - 2:30 pm | Q & A |
| 2:30 - 3:00 pm | Advances in the Management of Advanced RCC Pedro Barata, MD |
| 3:00 - 3:15 pm | Q & A |
| 3:15 - 3:50 pm | End of Lectures/Coffee Break |
